Safety and feasibility of dobutamine-atropine stress echocardiography;Seguranca e exequibilidade da ecocardiografia com estresse pela dobutamina associada a atropina

Arquivos Brasileiros de Cardiologia

Volumn 69, Issue 1, 1997, Pages 31-34

  Mathias Jr , Wilson ^a,b   Beneti, Léa Paula ^a   Dos Santos, Fabio Cesar ^a   Duprat, Renata ^a   Beraldo, Ailton ^a   Gil, Manoel Adan ^a   Andrade, José Lázaro ^a   Martinez, Eulógio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

coronary artery disease; dobutamine; echocardiography

Indexed keywords

ATROPINE; DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORONARY ARTERY DISEASE; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; STRESS; CLINICAL TRIAL; ECHOGRAPHY; EXERCISE TEST; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATROPINE; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; DOBUTAMINE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 9844263752     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x1997000700005     Document Type: Article

References (13)

1. Turtle RR, Mills J-Dobutamine development of a new cathecholamine to increase cardiac contractility. Circ Res 1975; 36: 185-96.
2. Berthe C, Pierard SA, Hiemaux M et al-Predicting the extant and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986; 58: 1167-72.
3. MacNeill A, Fioretti PM, El Said EM et al-Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine echocardiography. Am J Caidiol 1992; 70: 41-6.
4. Segar DS, Brown SE, Sawada SG et al - Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992; 19: 1197-202.
5. Mertes H, Sawada S, Ryan T et al-Symptons, adverse effects and complications associated with dobutamine stress echocardiography; experience in 1118 patients Circulation 1993; 88: 15-19.
6. Poldermans D, Fiorette PM, Boersma E et al. -Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease: experience in 650 consecutive examinations. Am J Cardiol 1994; 73: 456-9.
7. Picano E, Mathias W, Pingitore A et al - Safety and tolerability of dobutamineatropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190-2.
8. Shiller N, Shah P, Crawford M et al- Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echo 1989; 2: 358-67.
9. Ziskind AA - Transdermal scopolamine-induced psychosis. Postgrad Med 1988; 84: 73-6.
10. Wilkinson JA-Side effects of transdermal scopolamine. J Emerg Med 1987; 5: 389-92.
11. Stuart RJ, Ellestad MH-Natural survey of exercise stress testing facilities. Chest 1980; 77: 94.
12. Kawano H, Fuji H - Induction of coronary spasm during dobutamine stress echocardiography. Circulation 1998; 92(suppl I): no424.
13. Arena F, Paglioroni T, Michael TW, Galloway T, Bommer WJ, Lewis WR -Platelet activation during dobutamine stress echo. Circulation 1995; 92(suppl I):no 335.